These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 28622640

  • 1. Clinical course and core variability in HBV infected patients without detectable anti-HBc antibodies.
    Anastasiou OE, Widera M, Verheyen J, Korth J, Gerken G, Helfritz FA, Canbay A, Wedemeyer H, Ciesek S.
    J Clin Virol; 2017 Aug; 93():46-52. PubMed ID: 28622640
    [Abstract] [Full Text] [Related]

  • 2. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Coffin CS, Mulrooney-Cousins PM, Osiowy C, van der Meer F, Nishikawa S, Michalak TI, van Marle G, Gill MJ.
    J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
    [Abstract] [Full Text] [Related]

  • 3. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 4. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [Abstract] [Full Text] [Related]

  • 5. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection].
    Colomina-Rodríguez J, González-García D, Burgos-Teruel A, Fernández-Lorenz N, Guerrero-Espejo A.
    Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):80-5. PubMed ID: 15743579
    [Abstract] [Full Text] [Related]

  • 6. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
    Launay O, Masurel J, Servant-Delmas A, Basse-Guérineau AL, Méritet JF, Laperche S, Sogni P, Rosenberg AR.
    J Viral Hepat; 2011 Oct; 18(10):721-9. PubMed ID: 21914087
    [Abstract] [Full Text] [Related]

  • 7. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
    Yuan Q, Song LW, Cavallone D, Moriconi F, Cherubini B, Colombatto P, Oliveri F, Coco BA, Ricco G, Bonino F, Shih JW, Xia NS, Brunetto MR.
    PLoS One; 2015 Oct; 10(6):e0130209. PubMed ID: 26115521
    [Abstract] [Full Text] [Related]

  • 8. Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.
    Vargas JI, Jensen D, Sarmiento V, Peirano F, Acuña P, Fuster F, Soto S, Ahumada R, Huilcaman M, Bruna M, Jensen W, Fuster F.
    J Med Virol; 2016 Apr; 88(4):639-46. PubMed ID: 26381185
    [Abstract] [Full Text] [Related]

  • 9. Occult HBV among Anti-HBc Alone: Mutation Analysis of an HBV Surface Gene and Pre-S Gene.
    Kim MH, Kang SY, Lee WI.
    Yonsei Med J; 2017 May; 58(3):557-563. PubMed ID: 28332361
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.
    Karimi G, Zadsar M, Vafaei N, Sharifi Z, FalahTafti M.
    Virol J; 2016 Mar 05; 13():36. PubMed ID: 26944046
    [Abstract] [Full Text] [Related]

  • 11. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M.
    Haematologica; 2007 Dec 05; 92(12):1664-70. PubMed ID: 18055990
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of "anti-HBc alone" and HBV DNA detection among anti-HBc alone in Korea.
    Kang SY, Kim MH, Lee WI.
    J Med Virol; 2010 Sep 05; 82(9):1508-14. PubMed ID: 20648604
    [Abstract] [Full Text] [Related]

  • 13. The significance of 'anti-HBc only' in the clinical virology laboratory.
    Alhababi F, Sallam TA, Tong CY.
    J Clin Virol; 2003 Jul 05; 27(2):162-9. PubMed ID: 12829038
    [Abstract] [Full Text] [Related]

  • 14. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar 05; 21(3):189-91. PubMed ID: 23967739
    [Abstract] [Full Text] [Related]

  • 15. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep 05; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 16. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen.
    Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, Chiba T.
    Hepatology; 2000 Feb 05; 31(2):488-95. PubMed ID: 10655275
    [Abstract] [Full Text] [Related]

  • 17. The reliability of HBV core antibody in serological screening for hepatitis B virus.
    Ba Alawi F, Robertson PW, LePage AK, Jayamaha J, Baleriola C, Rawlinson WD.
    Pathology; 2013 Aug 05; 45(5):501-5. PubMed ID: 23842045
    [Abstract] [Full Text] [Related]

  • 18. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L, Strong DM, Tegtmeier G, Stramer S.
    Transfusion; 2008 Nov 05; 48(11):2315-22. PubMed ID: 18647367
    [Abstract] [Full Text] [Related]

  • 19. Nucleotide sequence of the precore/core gene and X gene of hepatitis B virus DNA in asymptomatic hepatitis B virus carriers who are negative for serum hepatitis B core antibody.
    Terada T, Moriyama M, Uchida T, Arakawa Y.
    Intervirology; 2001 Nov 05; 44(4):243-9. PubMed ID: 11509887
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.
    Biol Blood Marrow Transplant; 2010 Jun 05; 16(6):809-17. PubMed ID: 20060484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.